JP2024518665A5 - - Google Patents
Info
- Publication number
- JP2024518665A5 JP2024518665A5 JP2024515284A JP2024515284A JP2024518665A5 JP 2024518665 A5 JP2024518665 A5 JP 2024518665A5 JP 2024515284 A JP2024515284 A JP 2024515284A JP 2024515284 A JP2024515284 A JP 2024515284A JP 2024518665 A5 JP2024518665 A5 JP 2024518665A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- nucleic acid
- acid molecule
- individual
- isolated nucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163188573P | 2021-05-14 | 2021-05-14 | |
| US63/188,573 | 2021-05-14 | ||
| PCT/US2022/029213 WO2022241228A2 (en) | 2021-05-14 | 2022-05-13 | Variants of sirt6 for use in preventing and/or treating age-related diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518665A JP2024518665A (ja) | 2024-05-01 |
| JP2024518665A5 true JP2024518665A5 (https=) | 2025-05-20 |
Family
ID=84029856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515284A Pending JP2024518665A (ja) | 2021-05-14 | 2022-05-13 | 加齢に伴う疾患を防止および／または処置することにおける使用のためのｓｉｒｔ６のバリアント |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240277868A1 (https=) |
| EP (1) | EP4338267A4 (https=) |
| JP (1) | JP2024518665A (https=) |
| CA (1) | CA3218849A1 (https=) |
| WO (1) | WO2022241228A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4630038A1 (en) * | 2022-12-08 | 2025-10-15 | Genflow Biosciences Srl | Variants of sirtuin 6 for the treatment of non-alcoholic fatty liver disease |
| EP4665406A1 (en) * | 2023-02-14 | 2025-12-24 | The Trustees of Columbia University in the City of New York | Crispr-transposon systems and components |
| WO2026062177A1 (en) | 2024-09-20 | 2026-03-26 | Genflow Biosciences Srl | Variants of sirtuin 6 for the treatment of muscular diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110113498A1 (en) * | 2008-05-15 | 2011-05-12 | Westphal Christoph H | Sirt1 polymorphic variants and methods of use thereof |
| JP2015193582A (ja) * | 2014-03-28 | 2015-11-05 | 国立大学法人 東京大学 | イミダゾールジペプチドを含む剤 |
| WO2017201425A1 (en) * | 2016-05-20 | 2017-11-23 | The Trustees Columbia University In The City Of New York | Anabolic enhancers for ameliorating neurodegeneration |
| AU2017378427A1 (en) * | 2016-12-14 | 2019-06-20 | Ligandal, Inc. | Methods and compositions for nucleic acid and protein payload delivery |
-
2022
- 2022-05-13 CA CA3218849A patent/CA3218849A1/en active Pending
- 2022-05-13 US US18/560,828 patent/US20240277868A1/en active Pending
- 2022-05-13 EP EP22808414.1A patent/EP4338267A4/en active Pending
- 2022-05-13 JP JP2024515284A patent/JP2024518665A/ja active Pending
- 2022-05-13 WO PCT/US2022/029213 patent/WO2022241228A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024518665A5 (https=) | ||
| JP2021520198A5 (https=) | ||
| AU2016344508B2 (en) | Genetic construct | |
| JP2023109992A5 (https=) | ||
| JP2025120285A5 (https=) | ||
| US20200325454A1 (en) | VECTORS CONTAINING AIMP2-DX2 AND TARGET NUCLEIC ACIDS FOR miR 142 AND USES THEREOF | |
| TWI893130B (zh) | 編碼ｓｍｎ１蛋白的密碼子優化核酸及其用途 | |
| JP2023513004A5 (https=) | ||
| CA2859920A1 (en) | Variants of yeast ndi1 gene, and uses thereof in the treatment of disease associated with mitochondrial dysfunction | |
| JP2017512822A (ja) | 新規用途のためのガラクトシド阻害物質 | |
| JP2023539368A5 (https=) | ||
| JP2024119900A (ja) | 優性遺伝性カテコラミン誘発多形性心室頻拍の治療のための組成物および方法 | |
| JP2023529371A (ja) | シヌクレイノパチーの処置のための組成物および方法 | |
| JP2023544141A (ja) | ＡＩＭＰ２－ＤＸ２および必要に応じてｍｉＲ－１４２の標的配列ならびにその組成物を使用した神経系疾患を処置する方法 | |
| WO2021228052A1 (zh) | 生物大分子靶向特异性补体抑制剂及其制备方法与应用 | |
| JP2022543446A (ja) | Ａｐｏｅ４ ｒｎａ特異的トランススプライシングリボザイム及びその用途 | |
| JP2024514193A (ja) | ウイルス系の遺伝子治療のためのプロモータ | |
| KR20240128579A (ko) | Cd38 또는 이의 단편을 포함하는 자가면역질환 치료용 조성물 | |
| JP2023539367A5 (https=) | ||
| WO2019146745A1 (ja) | テイ－サックス病及びザンドホッフ病治療用の新規アデノ随伴ウイルスビリオン | |
| JP2021513871A5 (https=) | ||
| US20250092105A1 (en) | Granulin/epithelin modules and combinations thereof to treat neurodegenerative disease | |
| JP2023505271A5 (https=) | ||
| KR102626543B1 (ko) | AIMP2-DX2 및 miR-142의 표적 핵산을 포함하는 재조합 벡터 | |
| KR20250083388A (ko) | 신규한 케모카인-유사 단백질 단편 |